Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes
Principal investigatorDr. David Strobl, DO
Trial CategoryHeart & Vascular
Trial SubCategoryLipid Management
Unsupported Browser! This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.